Patent ID: 11964948
Assignee: ACTINIUM PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 21:
22. The method of claim 21, wherein the radionuclide is 134Ce, 43Sc, 44Sc, 47Sc, 55Co, 60Cu, 61Cu, 62Cu, 64Cu, 67Cu, 66Ga, 67Ga, 68Ga, 86Y, 87Y, 90Y, 166Ho, 89Zr, 97Ru, 105Rh, 109Pd, 111In, 117mSn, 149Pm, 149Tb, 153Sm, 177Lu, 201Tl, 203Pb, 212Pb, 212Bi, 213Bi, 225Ac, or 227Th.